Published in Yonsei Med J on February 12, 2010
Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. J Nucl Med (2007) 1.97
Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med (1990) 1.77
PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation. J Nucl Cardiol (2003) 1.39
Heterogeneity of the hypoxic state in rat heart is determined at capillary level. Am J Physiol (1993) 1.07
Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med (1993) 0.99
Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol (1996) 0.99
Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography. Eur J Nucl Med (1998) 0.99
Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol (1998) 0.92
18F-deoxyglucose and the assessment of myocardial viability. Semin Nucl Med (2002) 0.90
PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting. J Nucl Cardiol (2003) 0.90
Evaluation of patterns of perfusion and metabolism in dobutamine-responsive myocardium. J Am Coll Cardiol (1997) 0.86
The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. J Nucl Med (1993) 0.86
Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease. Eur J Nucl Med (1992) 0.83
Local myocardial glucose uptake is proportional to, but not dependent on blood flow. Pflugers Arch (1997) 0.83
Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols. Eur J Nucl Med (1997) 0.83
Accuracy of PET in predicting functional recovery after revascularisation in patients with chronic ischaemic dysfunction: head-to-head comparison between blood flow, glucose utilisation and water-perfusable tissue fraction. Eur J Nucl Med Mol Imaging (2002) 0.82
Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET images. J Nucl Med (1992) 0.81
Microheterogeneity of myocardial blood flow in rabbit hearts during normoxic and hypoxic states. Am J Physiol (1996) 0.80
Three-dimensional microstructural abnormality of the coronary capillary network after myocardial reperfusion--comparison between 'reflow' and 'no-reflow'. Circ J (2004) 0.78
Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med (2006) 2.57
Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial. Stroke (2005) 2.56
Real-time 3-dimensional echocardiographic assessment of left ventricular dyssynchrony: pitfalls in patients with dilated cardiomyopathy. JACC Cardiovasc Imaging (2009) 2.08
The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res (2003) 2.01
Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res (2008) 1.92
Assessment of coronary microcirculation in patients with takotsubo-like left ventricular dysfunction. Circ J (2005) 1.91
Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol (2006) 1.89
Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Hypertension (2008) 1.81
Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk. J Clin Endocrinol Metab (2012) 1.74
The relationship between coronary plaque characteristics and small embolic particles during coronary stent implantation. J Am Coll Cardiol (2007) 1.72
Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer (2002) 1.69
Japanese 2011 guidelines for prevention and treatment of osteoporosis--executive summary. Arch Osteoporos (2012) 1.69
Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability. Hypertension (2008) 1.62
Mesenchymal-epithelial interactions in the skin: increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation. J Cell Biol (2004) 1.56
Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res (2003) 1.56
A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study. Bone (2011) 1.55
Effects of intra-aortic balloon counterpulsation on coronary pressure in patients with stenotic coronary arteries. Am Heart J (2007) 1.55
Assessment of coronary arterial plaque by optical coherence tomography. Am J Cardiol (2006) 1.55
Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J (2006) 1.54
Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia. FEBS Lett (2002) 1.51
A case of platypnea orthodeoxia syndrome: a persistent history taking was the key to the diagnosis. Intern Med (2012) 1.48
Influence of chronic tethering of the mitral valve on mitral leaflet size and coaptation in functional mitral regurgitation. JACC Cardiovasc Imaging (2012) 1.48
Different determinants of residual tricuspid regurgitation after tricuspid annuloplasty: comparison of atrial septal defect and mitral valve prolapse. J Am Soc Echocardiogr (2009) 1.46
Mitral annulus flattens in ischemic mitral regurgitation: geometric differences between inferior and anterior myocardial infarction: a real-time 3-dimensional echocardiographic study. Circulation (2005) 1.46
Evaluation of coronary endothelial function by catheter-type NO sensor in high-fat-diet-induced obese dogs. Circ J (2009) 1.45
Hip structural analysis: a comparison of DXA with CT in postmenopausal Japanese women. Springerplus (2013) 1.45
Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging (2008) 1.43
Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene (2004) 1.42
Impact of statin therapy on systemic inflammation, left ventricular systolic and diastolic function and prognosis in low risk ischemic heart disease patients without history of congestive heart failure. Intern Med (2007) 1.41
Additive value of nicorandil on ATP for further inducing hyperemia in patients with an intermediate coronary artery stenosis. Coron Artery Dis (2017) 1.39
Risk Factors for Progression of Degenerative Aortic Valve Disease in the Japanese- The Japanese Aortic Stenosis Study (JASS) Prospective Analysis. Circ J (2015) 1.39
[Three cases of uveitis induced by mycobacteriosis therapy using rifabutin]. Nippon Ganka Gakkai Zasshi (2011) 1.39
Plaque characteristics of thin-cap fibroatheroma evaluated by OCT and IVUS. JACC Cardiovasc Imaging (2011) 1.37
Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells. Cancer Res (2006) 1.35
The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res (2006) 1.35
Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study. J Bone Miner Metab (2005) 1.34
Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004). J Bone Miner Metab (2005) 1.33
Comprehensive evaluation of left ventricular strain using speckle tracking echocardiography in normal adults: comparison of three-dimensional and two-dimensional approaches. J Am Soc Echocardiogr (2009) 1.32
Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology (2008) 1.29
FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis. Oncogene (2005) 1.29
Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition). J Bone Miner Metab (2012) 1.27
RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer. Cancer Res (2008) 1.27
Quantitation of mitral valve tenting in ischemic mitral regurgitation by transthoracic real-time three-dimensional echocardiography. J Am Coll Cardiol (2005) 1.26
Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest. J Bone Miner Res (2004) 1.26
Diagnostic criteria for primary osteoporosis: year 2012 revision. J Bone Miner Metab (2013) 1.24
Age- and gender-specific changes in the left ventricular relaxation: a Doppler echocardiographic study in healthy individuals. Circ Cardiovasc Imaging (2009) 1.23
Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial. Fertil Steril (2008) 1.23
Androgen-inducible TGF-beta1 from balding dermal papilla cells inhibits epithelial cell growth: a clue to understand paradoxical effects of androgen on human hair growth. FASEB J (2002) 1.21
Long-term prognosis of patients with type a aortic intramural hematoma. Circulation (2002) 1.19
A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial. J Bone Miner Metab (2004) 1.19
Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab (2005) 1.17
PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Cancer Res (2004) 1.16
A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab (2005) 1.16
STAT3 deficiency in keratinocytes leads to compromised cell migration through hyperphosphorylation of p130(cas). J Biol Chem (2002) 1.16
Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes. Eur J Immunol (2003) 1.14
Local release of catecholamines from the hearts of patients with tako-tsubo-like left ventricular dysfunction. Circ J (2008) 1.11
Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: a subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene. Hum Pathol (2004) 1.10
A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo-controlled trial. J Bone Miner Res (2010) 1.09
Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02. Curr Med Res Opin (2011) 1.09
A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis. Bone (2009) 1.09
Pseudoangiomatous stromal hyperplasia (PASH) of the mammary gland: report of a case. Surg Today (2008) 1.07
Two cases of acute bioprosthetic mitral valve thrombosis immediately after mitral valve replacement. Circulation (2014) 1.06
Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT. Bone (2011) 1.06
A case of thoracic hemorrhage due to ectopic parathyroid hyperplasia with chronic renal failure. Am J Kidney Dis (2005) 1.06
Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen. J Bone Miner Metab (2006) 1.06
Identification of GFAP gene mutation in hereditary adult-onset Alexander's disease. Ann Neurol (2002) 1.06
Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: a 3-year follow-up study. J Bone Miner Metab (2004) 1.05
Assessment of regional myocardial strain by a novel automated tracking system from digital image files. J Am Soc Echocardiogr (2004) 1.05
Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging (2009) 1.05
Clinical Trials Express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT). J Clin Endocrinol Metab (2014) 1.05
Assessment of the coronary calcification by optical coherence tomography. EuroIntervention (2011) 1.04
A case of stroke due to tumor emboli associated with metastatic cardiac liposarcoma. Intern Med (2011) 1.04
Guidelines for diagnosis and management of Paget's disease of bone in Japan. J Bone Miner Metab (2006) 1.04
Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues. J Magn Reson Imaging (2008) 1.03
c-kit gene mutations in intracranial germinomas. Cancer Sci (2004) 1.02
Assessment of coronary intima--media thickness by optical coherence tomography: comparison with intravascular ultrasound. Circ J (2005) 1.02
Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures. J Bone Miner Metab (2008) 1.02